The glucagon-like peptides

被引：837

作者：

Kieffer, TJ

Habener, JL

机构：

[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Howard Hughes Med Inst,Lab Mol Endocrinol, Boston, MA 02114 USA

[2] Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada

[3] Univ Alberta, Dept Physiol, Edmonton, AB T6G 2S2, Canada

来源：

ENDOCRINE REVIEWS | 1999年 / 20卷 / 06期

关键词：

D O I：

10.1210/er.20.6.876

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：876 / 913

页数：38

共 587 条

[91] GLUCAGON-LIKE PEPTIDE-1 ENHANCES GLUCOSE-TOLERANCE BOTH BY STIMULATION OF INSULIN RELEASE AND BY INCREASING INSULIN-INDEPENDENT GLUCOSE DISPOSAL [J].

DALESSIO, DA ;

KAHN, SE ;

LEUSNER, CR ;

ENSINCK, JW .

JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (05) :2263-2266

[92] Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons [J].

DAlessio, DA ;

Vogel, R ;

Prigeon, R ;

Laschansky, E ;

Koerker, D ;

Eng, J ;

Ensinck, JW .

JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (01) :133-138

[93] ENTERAL ENHANCEMENT OF GLUCOSE DISPOSITION BY BOTH INSULIN-DEPENDENT AND INSULIN-INDEPENDENT PROCESSES - A PHYSIOLOGICAL-ROLE OF GLUCAGON-LIKE PEPTIDE-I [J].

DALESSIO, DA ;

PRIGEON, RL ;

ENSINCK, JW .

DIABETES, 1995, 44 (12) :1433-1437

[94] Glucagon-like-peptide-1 secretion from canine L-cells is increased by glucose-dependent insulinotropic peptide but unaffected by glucose [J].

Damholt, AB ;

Buchan, AMJ ;

Kofod, H .

ENDOCRINOLOGY, 1998, 139 (04) :2085-2091

[95] REGIONAL EXPRESSION OF EPITHELIAL DIPEPTIDYL PEPTIDASE-IV IN THE HUMAN INTESTINES [J].

DARMOUL, D ;

VOISIN, T ;

COUVINEAU, A ;

ROUYERFESSARD, C ;

SALOMON, R ;

WANG, YX ;

SWALLOW, DM ;

LABURTHE, M .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 203 (02) :1224-1229

[96] DIPEPTIDYL PEPTIDASE IV EXPRESSION IN RAT JEJUNAL CRYPT-VILLUS AXIS IS CONTROLLED AT MESSENGER-RNA LEVEL [J].

DARMOUL, D ;

ROUYERFESSARD, C ;

BLAIS, A ;

VOISIN, T ;

SAPIN, C ;

BARICAULT, L ;

CIBERT, C ;

GERAUD, G ;

COUVINEAU, A ;

LABURTHE, M ;

TRUGNAN, G .

AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (05) :G763-G769

[97] Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig [J].

Deacon, CF ;

Hughes, TE ;

Holst, JJ .

DIABETES, 1998, 47 (05) :764-769

[98] Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity [J].

Deacon, CF ;

Knudsen, LB ;

Madsen, K ;

Wiberg, FC ;

Jacobsen, O ;

Holst, JJ .

DIABETOLOGIA, 1998, 41 (03) :271-278

[99] BOTH SUBCUTANEOUSLY AND INTRAVENOUSLY ADMINISTERED GLUCAGON-LIKE PEPTIDE-I ARE RAPIDLY DEGRADED FROM THE NH2-TERMINUS IN TYPE-II DIABETIC-PATIENTS AND IN HEALTHY-SUBJECTS [J].

DEACON, CF ;

NAUCK, MA ;

TOFTNIELSEN, M ;

PRIDAL, L ;

WILLMS, B ;

HOLST, JJ .

DIABETES, 1995, 44 (09) :1126-1131

[100] DEGRADATION OF GLUCAGON-LIKE PEPTIDE-1 BY HUMAN PLASMA IN-VITRO YIELDS AN N-TERMINALLY TRUNCATED PEPTIDE THAT IS A MAJOR ENDOGENOUS METABOLITE IN-VIVO [J].

DEACON, CF ;

JOHNSEN, AH ;

HOLST, JJ .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (03) :952-957

← 5 6 7 8 9 10 11 12 13 14 →